{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:19:17Z","timestamp":1794579557948,"version":"4.9.1"},"reference-count":77,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Fibromyalgia (FM) is a disease primarily associated with chronic widespread pain, but other common symptoms are anxiety and depression. We previously proposed that autoimmunity contributes to FM based on findings of increased immunoglobulin G binding to satellite glial cells (anti-SGC IgG) in FM subjects compared to healthy controls (HC). Emerging research suggests that an altered gut microbiota composition is connected to psychological symptoms in FM. Gut microbiota can produce or alter bile acids (BAs) and short-chain fatty acids (SCFAs), which have important immune and inflammatory functions. Here, we investigate alterations in BA and SCFA concentrations in FM subjects compared to HC and potential associations with FM symptoms and anti-SGC IgG levels. Bile acids and SCFAs were quantified using liquid chromatography coupled with high-resolution mass spectrometry and anti-SGC IgG levels were assessed with immunocytochemistry. The correlations between FM symptoms, anti-SGC IgG levels, and serum concentrations of 24 BAs and 11 SCFAs in 35 FM subjects and 32 matched HC were examined. Fibromyalgia subjects had significantly higher levels of non-conjugated microbially produced (secondary) BAs compared to HC. Additionally, total BA levels were significantly elevated in FM subjects with high, compared to those with low, anti-SGC IgG levels. Concentrations of specific BAs were associated with increased disease severity and poorer mental well-being. These results revealed increased levels of non-conjugated secondary BAs in FM subjects compared to HC. The strong association between BAs, anti-SGC IgG levels, and mental well-being may help elucidate the importance of BAs in the psychological symptoms of FM.<\/jats:p>","DOI":"10.1038\/s41598-026-40781-3","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T10:36:04Z","timestamp":1771929364000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Microbially produced bile acids are associated with increased IgG autoantibodies and poorer mental wellbeing in fibromyalgia"],"prefix":"10.1038","volume":"16","author":[{"given":"Jenny E.","family":"Jakobsson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ida","family":"Erngren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Menezes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emerson","family":"Krock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Tour Sohlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asma","family":"Al-Grety","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katalin","family":"Sandor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kosek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla I.","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Kultima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"40781_CR1","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41584-020-00506-w","volume":"16","author":"P Sarzi-Puttini","year":"2020","unstructured":"Sarzi-Puttini, P., Giorgi, V., Marotto, D. & Atzeni, F. Fibromyalgia: An update on clinical characteristics, aetiopathogenesis and treatment. Nat. Rev. Rheumatol. 16, 645\u2013660 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"40781_CR2","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00296-017-3725-2","volume":"37","author":"F Heidari","year":"2017","unstructured":"Heidari, F., Afshari, M. & Moosazadeh, M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol. Int. 37, 1527\u20131539 (2017).","journal-title":"Rheumatol. Int."},{"key":"40781_CR3","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.semarthrit.2008.12.003","volume":"39","author":"JC Branco","year":"2010","unstructured":"Branco, J. C. et al. Prevalence of fibromyalgia: A survey in five European countries. Semin Arthritis Rheum. 39, 448\u2013453 (2010).","journal-title":"Semin Arthritis Rheum."},{"key":"40781_CR4","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1016\/S0140-6736(21)00392-5","volume":"397","author":"MA Fitzcharles","year":"2021","unstructured":"Fitzcharles, M. A. et al. Nociplastic pain: Towards an understanding of prevalent pain conditions. Lancet 397, 2098\u20132110 (2021).","journal-title":"Lancet"},{"key":"40781_CR5","doi-asserted-by":"crossref","unstructured":"Kosek, E. The concept of nociplastic pain-Where to from here? Pain 165, S50\u2013S57 (2024).","DOI":"10.1097\/j.pain.0000000000003305"},{"key":"40781_CR6","doi-asserted-by":"publisher","first-page":"1565","DOI":"10.1002\/ejp.1252","volume":"22","author":"MA Fitzcharles","year":"2018","unstructured":"Fitzcharles, M. A., Perrot, S. & H\u00e4user, W. Comorbid fibromyalgia: A qualitative review of prevalence and importance. Eur. J. Pain. 22, 1565\u20131576 (2018).","journal-title":"Eur. J. Pain"},{"key":"40781_CR7","unstructured":"Goebel, A. et al. Passive transfer of fibromyalgia symptoms from patients to mice. J. Clin. Invest. 131 (2021)."},{"key":"40781_CR8","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1002\/ana.25565","volume":"86","author":"D Evdokimov","year":"2019","unstructured":"Evdokimov, D. et al. Reduction of skin innervation is associated with a severe fibromyalgia phenotype. Ann. Neurol. 86, 504\u2013516 (2019).","journal-title":"Ann. Neurol."},{"key":"40781_CR9","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1097\/j.pain.0000000000002881","volume":"164","author":"E Krock","year":"2023","unstructured":"Krock, E. et al. Fibromyalgia patients with elevated levels of anti-satellite glia cell immunoglobulin G antibodies present with more severe symptoms. Pain 164, 1828\u20131840 (2023).","journal-title":"Pain"},{"key":"40781_CR10","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","volume":"19","author":"CD Fuchs","year":"2022","unstructured":"Fuchs, C. D. & Trauner, M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat. Rev. Gastroenterol. Hepatol. 19, 432\u2013450 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"40781_CR11","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/j.2040-4603.2020.tb00108.x","volume":"10","author":"AL Ticho","year":"2019","unstructured":"Ticho, A. L., Malhotra, P., Dudeja, P. K., Gill, R. K. & Alrefai, W. A. Intestinal absorption of bile acids in health and disease. Compr. Physiol. 10, 21\u201356 (2019).","journal-title":"Compr. Physiol."},{"key":"40781_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/apt.13227","volume":"42","author":"SA Slattery","year":"2015","unstructured":"Slattery, S. A., Niaz, O., Aziz, Q., Ford, A. C. & Farmer, A. D. Systematic review with meta-analysis: The prevalence of bile acid malabsorption in the irritable bowel syndrome with diarrhoea. Aliment. Pharmacol. Ther. 42, 3\u201311 (2015).","journal-title":"Aliment. Pharmacol. Ther."},{"key":"40781_CR13","doi-asserted-by":"publisher","first-page":"e14287","DOI":"10.1111\/nmo.14287","volume":"34","author":"M Camilleri","year":"2022","unstructured":"Camilleri, M. & Nurko, S. Bile acid diarrhea in adults and adolescents. Neurogastroenterol Motil. 34, e14287 (2022).","journal-title":"Neurogastroenterol Motil."},{"key":"40781_CR14","doi-asserted-by":"publisher","first-page":"e66","DOI":"10.1097\/j.pain.0000000000002694","volume":"164","author":"A Minerbi","year":"2023","unstructured":"Minerbi, A. et al. Altered serum bile acid profile in fibromyalgia is associated with specific gut microbiome changes and symptom severity. Pain 164, e66\u2013e76 (2023).","journal-title":"Pain"},{"key":"40781_CR15","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1097\/j.pain.0000000000001640","volume":"160","author":"A Minerbi","year":"2019","unstructured":"Minerbi, A. et al. Altered microbiome composition in individuals with fibromyalgia. Pain 160, 2589\u20132602 (2019).","journal-title":"Pain"},{"key":"40781_CR16","unstructured":"Cai, W. et al. The gut microbiota promotes pain in fibromyalgia. Neuron  (2025)."},{"key":"40781_CR17","doi-asserted-by":"publisher","first-page":"114620","DOI":"10.1016\/j.biopha.2023.114620","volume":"162","author":"A Rasouli-Saravani","year":"2023","unstructured":"Rasouli-Saravani, A. et al. Role of microbiota short-chain fatty acids in the pathogenesis of autoimmune diseases. Biomed. Pharmacother. 162, 114620 (2023).","journal-title":"Biomed. Pharmacother"},{"key":"40781_CR18","doi-asserted-by":"publisher","first-page":"174480692199652","DOI":"10.1177\/1744806921996520","volume":"17","author":"F Zhou","year":"2021","unstructured":"Zhou, F. et al. Short-chain fatty acids contribute to neuropathic pain via regulating microglia activation and polarization. Mol. Pain. 17, 1744806921996520 (2021).","journal-title":"Mol. Pain"},{"key":"40781_CR19","doi-asserted-by":"publisher","first-page":"e0277427","DOI":"10.1371\/journal.pone.0277427","volume":"17","author":"J Tour","year":"2022","unstructured":"Tour, J., Sandstr\u00f6m, A., Kadetoff, D., Schalling, M. & Kosek, E. The OPRM1 gene and interactions with the 5-HT1a gene regulate conditioned pain modulation in fibromyalgia patients and healthy controls. PLoS One. 17, e0277427 (2022).","journal-title":"PLoS One"},{"key":"40781_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1186\/s13041-021-00789-4","volume":"14","author":"I Ellerbrock","year":"2021","unstructured":"Ellerbrock, I. et al. Serotonergic gene-to-gene interaction is associated with mood and GABA concentrations but not with pain-related cerebral processing in fibromyalgia subjects and healthy controls. Mol. Brain. 14, 81 (2021).","journal-title":"Mol. Brain"},{"key":"40781_CR21","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/ejp.1680","volume":"25","author":"I Ellerbrock","year":"2021","unstructured":"Ellerbrock, I. et al. Polymorphisms of the \u00b5-opioid receptor gene influence cerebral pain processing in fibromyalgia. Eur. J. Pain. 25, 398\u2013414 (2021).","journal-title":"Eur. J. Pain"},{"key":"40781_CR22","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1097\/j.pain.0000000000001907","volume":"161","author":"A Sandstr\u00f6m","year":"2020","unstructured":"Sandstr\u00f6m, A. et al. Neural correlates of conditioned pain responses in fibromyalgia subjects indicate preferential formation of new pain associations rather than extinction of irrelevant ones. Pain 161, 2079\u20132088 (2020).","journal-title":"Pain"},{"key":"40781_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.bbi.2023.09.003","volume":"114","author":"S Fanton","year":"2023","unstructured":"Fanton, S. et al. Anti-satellite glia cell IgG antibodies in fibromyalgia patients are related to symptom severity and to metabolite concentrations in thalamus and rostral anterior cingulate cortex. Brain Behav. Immun. 114, 371\u2013382 (2023).","journal-title":"Brain Behav. Immun."},{"key":"40781_CR24","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1097\/j.pain.0000000000002309","volume":"163","author":"S Fanton","year":"2022","unstructured":"Fanton, S. et al. The translocator protein gene is associated with endogenous pain modulation and the balance between glutamate and \u03b3-aminobutyric acid in fibromyalgia and healthy subjects: A multimodal neuroimaging study: a multimodal neuroimaging study. Pain 163, 274\u2013286 (2022).","journal-title":"Pain"},{"key":"40781_CR25","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe, F. et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Report of the multicenter criteria committee. Arthritis Rheum. 33, 160\u2013172 (1990).","journal-title":"Arthritis Rheum."},{"key":"40781_CR26","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe, F. et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: A modification of the ACR preliminary diagnostic criteria for fibromyalgia. J. Rheumatol. 38, 1113\u20131122 (2011).","journal-title":"J. Rheumatol."},{"key":"40781_CR27","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe, F. et al. 2016 Revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 46, 319\u2013329 (2016).","journal-title":"Semin Arthritis Rheum."},{"key":"40781_CR28","first-page":"728","volume":"18","author":"CS Burckhardt","year":"1991","unstructured":"Burckhardt, C. S., Clark, S. R. & Bennett, R. M. The fibromyalgia impact questionnaire: Development and validation. J. Rheumatol. 18, 728\u2013733 (1991).","journal-title":"J. Rheumatol."},{"key":"40781_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1111\/j.1600-0447.1983.tb09716.x","volume":"67","author":"AS Zigmond","year":"1983","unstructured":"Zigmond, A. S. & Snaith, R. P. The hospital anxiety and depression scale. Acta Psychiatr Scand. 67, 361\u2013370 (1983).","journal-title":"Acta Psychiatr Scand."},{"key":"40781_CR30","doi-asserted-by":"publisher","first-page":"109497","DOI":"10.1016\/j.jneumeth.2022.109497","volume":"371","author":"MA Hunt","year":"2022","unstructured":"Hunt, M. A. et al. DRGquant: A new modular AI-based pipeline for 3D analysis of the DRG. J. Neurosci. Methods. 371, 109497 (2022).","journal-title":"J. Neurosci. Methods"},{"key":"40781_CR31","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1039\/D3EM00060E","volume":"25","author":"H Carlsson","year":"2023","unstructured":"Carlsson, H., Sreenivasan, A. P., Erngren, I., Larsson, A. & Kultima, K. Combining the targeted and untargeted screening of environmental contaminants reveals associations between PFAS exposure and vitamin D metabolism in human plasma. Environ. Sci. Process. Impacts. 25, 1116\u20131130 (2023).","journal-title":"Environ. Sci. Process. Impacts"},{"key":"40781_CR32","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1002\/j.2040-4603.2013.tb00517.x","volume":"3","author":"JYL Chiang","year":"2013","unstructured":"Chiang, J. Y. L. Bile acid metabolism and signaling. Compr. Physiol. 3, 1191\u20131212 (2013).","journal-title":"Compr. Physiol."},{"key":"40781_CR33","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s10067-005-0004-5","volume":"25","author":"G Gurer","year":"2006","unstructured":"Gurer, G., Sendur, O. F. & Ay, C. Serum lipid profile in fibromyalgia women. Clin. Rheumatol. 25, 300\u2013303 (2006).","journal-title":"Clin. Rheumatol."},{"key":"40781_CR34","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.metabol.2006.09.001","volume":"56","author":"BL Loevinger","year":"2007","unstructured":"Loevinger, B. L., Muller, D., Alonso, C. & Coe, C. L. Metabolic syndrome in women with chronic pain. Metabolism 56, 87\u201393 (2007).","journal-title":"Metabolism"},{"key":"40781_CR35","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s00296-012-2647-2","volume":"34","author":"MD Cordero","year":"2014","unstructured":"Cordero, M. D. et al. Clinical symptoms in fibromyalgia are associated to overweight and lipid profile. Rheumatol. Int. 34, 419\u2013422 (2014).","journal-title":"Rheumatol. Int."},{"key":"40781_CR36","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1177\/1099800415591035","volume":"18","author":"A Rus","year":"2016","unstructured":"Rus, A. et al. Nitric oxide, inflammation, lipid profile, and cortisol in normal- and overweight women with fibromyalgia. Biol. Res. Nurs. 18, 138\u2013146 (2016).","journal-title":"Biol. Res. Nurs."},{"key":"40781_CR37","doi-asserted-by":"publisher","first-page":"541","DOI":"10.3349\/ymj.2000.41.5.541","volume":"41","author":"S Ozgocmen","year":"2000","unstructured":"Ozgocmen, S. & Ardicoglu, O. Lipid profile in patients with fibromyalgia and myofascial pain syndromes. Yonsei Med. J. 41, 541\u2013545 (2000).","journal-title":"Yonsei Med. J."},{"key":"40781_CR38","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ebiom.2019.07.031","volume":"46","author":"M Clos-Garcia","year":"2019","unstructured":"Clos-Garcia, M. et al. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine 46, 499\u2013511 (2019).","journal-title":"EBioMedicine"},{"key":"40781_CR39","doi-asserted-by":"publisher","first-page":"1305361","DOI":"10.3389\/fmicb.2023.1305361","volume":"14","author":"Z Wang","year":"2023","unstructured":"Wang, Z., Jiang, D., Zhang, M., Teng, Y. & Huang, Y. Causal association between gut microbiota and fibromyalgia: A Mendelian randomization study. Front. Microbiol. 14, 1305361 (2023).","journal-title":"Front. Microbiol."},{"key":"40781_CR40","doi-asserted-by":"crossref","unstructured":"Nhu, N. T. et al. 1., Associations between brain-gut axis and psychological distress in fibromyalgia: A microbiota and magnetic resonance imaging study. J. Pain 25, 934\u2013945 (2024).","DOI":"10.1016\/j.jpain.2023.10.015"},{"key":"40781_CR41","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1093\/rheumatology\/ken140","volume":"47","author":"A Goebel","year":"2008","unstructured":"Goebel, A., Buhner, S., Schedel, R., Lochs, H. & Sprotte, G. Altered intestinal permeability in patients with primary fibromyalgia and in patients with complex regional pain syndrome. Rheumatology 47, 1223\u20131227 (2008).","journal-title":"Rheumatology"},{"key":"40781_CR42","doi-asserted-by":"publisher","first-page":"1253121","DOI":"10.3389\/fimmu.2023.1253121","volume":"14","author":"F Mart\u00edn","year":"2023","unstructured":"Mart\u00edn, F. et al. Increased gut permeability and bacterial translocation are associated with fibromyalgia and myalgic encephalomyelitis\/chronic fatigue syndrome: Implications for disease-related biomarker discovery. Front. Immunol. 14, 1253121 (2023).","journal-title":"Front. Immunol."},{"key":"40781_CR43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.2340\/16501977-0597","volume":"42","author":"D Kadetoff","year":"2010","unstructured":"Kadetoff, D. & Kosek, E. Evidence of reduced sympatho-adrenal and hypothalamic-pituitary activity during static muscular work in patients with fibromyalgia. J. Rehabil Med. 42, 765\u2013772 (2010).","journal-title":"J. Rehabil Med."},{"key":"40781_CR44","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.gtc.2005.02.007","volume":"34","author":"P Bercik","year":"2005","unstructured":"Bercik, P., Verdu, E. F. & Collins, S. M. Is irritable bowel syndrome a low-grade inflammatory bowel disease? Gastroenterol. Clin. North. Am. 34, 235\u2013245 (2005).","journal-title":"Gastroenterol. Clin. North. Am."},{"key":"40781_CR45","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1053\/j.gastro.2008.08.051","volume":"135","author":"RJ Traub","year":"2008","unstructured":"Traub, R. J. et al. A rat model of chronic postinflammatory visceral pain induced by deoxycholic acid. Gastroenterology 135, 2075\u20132083 (2008).","journal-title":"Gastroenterology"},{"key":"40781_CR46","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/wvn.12358","volume":"16","author":"P Palomo-L\u00f3pez","year":"2019","unstructured":"Palomo-L\u00f3pez, P. et al. Relationship of depression scores and ranges in women who suffer from fibromyalgia by age distribution: A case-control study. Worldviews Evid. Based Nurs. 16, 211\u2013220 (2019).","journal-title":"Worldviews Evid. Based Nurs."},{"key":"40781_CR47","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/pcn.13368","volume":"76","author":"N Sun","year":"2022","unstructured":"Sun, N. et al. Abnormal gut microbiota and bile acids in patients with first-episode major depressive disorder and correlation analysis. Psychiatry Clin. Neurosci. 76, 321\u2013328 (2022).","journal-title":"Psychiatry Clin. Neurosci."},{"key":"40781_CR48","doi-asserted-by":"publisher","first-page":"685594","DOI":"10.3389\/fnagi.2021.685594","volume":"13","author":"WJ Griffiths","year":"2021","unstructured":"Griffiths, W. J. et al. The cerebrospinal fluid profile of cholesterol metabolites in Parkinson\u2019s disease and their association with disease state and clinical features. Front. Aging Neurosci. 13, 685594 (2021).","journal-title":"Front. Aging Neurosci."},{"key":"40781_CR49","doi-asserted-by":"publisher","first-page":"e22100","DOI":"10.1096\/fj.202101088RRR","volume":"36","author":"L Feng","year":"2022","unstructured":"Feng, L. et al. Co-occurrence of gut microbiota dysbiosis and bile acid metabolism alteration is associated with psychological disorders in Crohn\u2019s disease. FASEB J. 36, e22100 (2022).","journal-title":"FASEB J."},{"key":"40781_CR50","doi-asserted-by":"publisher","first-page":"937906","DOI":"10.3389\/fnins.2022.937906","volume":"16","author":"S MahmoudianDehkordi","year":"2022","unstructured":"MahmoudianDehkordi, S. et al. Gut microbiome-linked metabolites in the pathobiology of major depression with or without anxiety-A role for bile acids. Front. Neurosci. 16, 937906 (2022).","journal-title":"Front. Neurosci."},{"key":"40781_CR51","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.3389\/fimmu.2018.01853","volume":"9","author":"S Fiorucci","year":"2018","unstructured":"Fiorucci, S., Biagioli, M., Zampella, A. & Distrutti, E. Bile acids activated receptors regulate innate immunity. Front. Immunol. 9, 1853 (2018).","journal-title":"Front. Immunol."},{"key":"40781_CR52","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.psychres.2018.04.025","volume":"264","author":"WG Chen","year":"2018","unstructured":"Chen, W. G., Zheng, J. X., Xu, X., Hu, Y. M. & Ma, Y. M. Hippocampal FXR plays a role in the pathogenesis of depression: A preliminary study based on lentiviral gene modulation. Psychiatry Res. 264, 374\u2013379 (2018).","journal-title":"Psychiatry Res."},{"key":"40781_CR53","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3389\/fnbeh.2015.00070","volume":"9","author":"F Huang","year":"2015","unstructured":"Huang, F. et al. Deletion of mouse FXR gene disturbs multiple neurotransmitter systems and alters neurobehavior. Front. Behav. Neurosci. 9, 70 (2015).","journal-title":"Front. Behav. Neurosci."},{"key":"40781_CR54","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jprot.2018.07.009","volume":"186","author":"JA Ram\u00edrez-Tejero","year":"2018","unstructured":"Ram\u00edrez-Tejero, J. A. et al. Insight into the biological pathways underlying fibromyalgia by a proteomic approach. J. Proteom. 186, 47\u201355 (2018).","journal-title":"J. Proteom."},{"key":"40781_CR55","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/j.jad.2023.10.072","volume":"344","author":"Y Tao","year":"2024","unstructured":"Tao, Y. et al. TGR5 deficiency-induced anxiety and depression-like behaviors: The role of gut microbiota dysbiosis. J. Affect. Disord. 344, 219\u2013232 (2024).","journal-title":"J. Affect. Disord"},{"key":"40781_CR56","doi-asserted-by":"publisher","first-page":"3467","DOI":"10.1172\/JCI129401","volume":"130","author":"P Bhargava","year":"2020","unstructured":"Bhargava, P. et al. Bile acid metabolism is altered in multiple sclerosis and supplementation ameliorates neuroinflammation. J. Clin. Invest. 130, 3467\u20133482 (2020).","journal-title":"J. Clin. Invest."},{"key":"40781_CR57","doi-asserted-by":"publisher","first-page":"100762","DOI":"10.1016\/j.xcrm.2022.100762","volume":"3","author":"S Lamichhane","year":"2022","unstructured":"Lamichhane, S. et al. Dysregulation of secondary bile acid metabolism precedes islet autoimmunity and type 1 diabetes. Cell. Rep. Med. 3, 100762 (2022).","journal-title":"Cell. Rep. Med."},{"key":"40781_CR58","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1002\/hep.1840120523","volume":"12","author":"DL Schmucker","year":"1990","unstructured":"Schmucker, D. L., Ohta, M., Kanai, S., Sato, Y. & Kitani, K. Hepatic injury induced by bile salts: Correlation between biochemical and morphological events. Hepatology 12, 1216\u20131221 (1990).","journal-title":"Hepatology"},{"key":"40781_CR59","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1002\/path.4983","volume":"243","author":"L Sheng","year":"2017","unstructured":"Sheng, L. et al. Hepatic inflammation caused by dysregulated bile acid synthesis is reversible by butyrate supplementation. J. Pathol. 243, 431\u2013441 (2017).","journal-title":"J. Pathol."},{"key":"40781_CR60","doi-asserted-by":"publisher","first-page":"2435","DOI":"10.1096\/fj.201800935RR","volume":"33","author":"WT Li","year":"2019","unstructured":"Li, W. T. et al. Bile acids induce visceral hypersensitivity via mucosal mast cell-to-nociceptor signaling that involves the farnesoid X receptor\/nerve growth factor\/transient receptor potential vanilloid 1 axis. FASEB J. 33, 2435\u20132450 (2019).","journal-title":"FASEB J."},{"key":"40781_CR61","doi-asserted-by":"publisher","first-page":"G275","DOI":"10.1152\/ajpgi.00016.2019","volume":"317","author":"Y Yu","year":"2019","unstructured":"Yu, Y. et al. Deoxycholic acid activates colonic afferent nerves via 5-HT3 receptor-dependent and -independent mechanisms. Am. J. Physiol. Gastrointest. Liver Physiol. 317, G275\u2013G284 (2019).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"40781_CR62","doi-asserted-by":"publisher","first-page":"113386","DOI":"10.1016\/j.celrep.2023.113386","volume":"42","author":"S Zhong","year":"2023","unstructured":"Zhong, S. et al. Blockade of CCR5 suppresses paclitaxel-induced peripheral neuropathic pain caused by increased deoxycholic acid. Cell. Rep. 42, 113386 (2023).","journal-title":"Cell. Rep."},{"key":"40781_CR63","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1172\/JCI64551","volume":"123","author":"F Alemi","year":"2013","unstructured":"Alemi, F. et al. The TGR5 receptor mediates bile acid-induced itch and analgesia. J. Clin. Invest. 123, 1513\u20131530 (2013).","journal-title":"J. Clin. Invest."},{"key":"40781_CR64","doi-asserted-by":"publisher","first-page":"111618","DOI":"10.1016\/j.mce.2022.111618","volume":"548","author":"JYL Chiang","year":"2022","unstructured":"Chiang, J. Y. L. & Ferrell, J. M. Discovery of farnesoid X receptor and its role in bile acid metabolism. Mol. Cell. Endocrinol. 548, 111618 (2022).","journal-title":"Mol. Cell. Endocrinol."},{"key":"40781_CR65","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.colsurfa.2006.02.009","volume":"280","author":"DB Warren","year":"2006","unstructured":"Warren, D. B., Chalmers, D. K., Hutchison, K., Dang, W. & Pouton, C. W. Molecular dynamics simulations of spontaneous bile salt aggregation. Colloids Surf. Physicochem Eng. Asp. 280, 182\u2013193 (2006).","journal-title":"Colloids Surf. Physicochem Eng. Asp"},{"key":"40781_CR66","doi-asserted-by":"publisher","first-page":"9435","DOI":"10.1074\/jbc.M209706200","volume":"278","author":"Y Kawamata","year":"2003","unstructured":"Kawamata, Y. et al. A G protein-coupled receptor responsive to bile acids. J. Biol. Chem. 278, 9435\u20139440 (2003).","journal-title":"J. Biol. Chem."},{"key":"40781_CR67","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3109\/00365529609094568","volume":"216","author":"PB Mortensen","year":"1996","unstructured":"Mortensen, P. B. & Clausen, M. R. Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease. Scand. J. Gastroenterol. Suppl. 216, 132\u2013148 (1996).","journal-title":"Scand. J. Gastroenterol. Suppl."},{"key":"40781_CR68","first-page":"1298340","volume":"28","author":"R Hemalatha","year":"2017","unstructured":"Hemalatha, R. et al. Effect of probiotic supplementation on total lactobacilli, bifidobacteria and short chain fatty acids in 2-5-year-old children. Microb. Ecol. Health Dis. 28, 1298340 (2017).","journal-title":"Microb. Ecol. Health Dis."},{"key":"40781_CR69","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s40291-023-00677-8","volume":"28","author":"A Rus","year":"2024","unstructured":"Rus, A. et al. Predictive ability of serum amino acid levels to differentiate fibromyalgia patients from healthy subjects. Mol. Diagn. Ther. 28, 113\u2013128 (2024).","journal-title":"Mol. Diagn. Ther."},{"key":"40781_CR70","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1080\/00365513.2016.1269362","volume":"77","author":"V Ruggiero","year":"2017","unstructured":"Ruggiero, V. et al. Free amino acids in fibromyalgia syndrome: Relationship with clinical picture. Scand. J. Clin. Lab. Invest. 77, 93\u201397 (2017).","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"40781_CR71","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1021\/acs.jproteome.3c00797","volume":"23","author":"L Whiley","year":"2024","unstructured":"Whiley, L. et al. Cross-validation of metabolic phenotypes in SARS-CoV-2 infected subpopulations using targeted liquid chromatography-mass spectrometry (LC-MS). J. Proteome Res. 23, 1313\u20131327 (2024).","journal-title":"J. Proteome Res."},{"key":"40781_CR72","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/cts.12679","volume":"13","author":"V Menzies","year":"2020","unstructured":"Menzies, V. et al. Metabolomic differentials in women with and without fibromyalgia. Clin. Transl Sci. 13, 67\u201377 (2020).","journal-title":"Clin. Transl Sci."},{"key":"40781_CR73","doi-asserted-by":"publisher","first-page":"R17","DOI":"10.1186\/ar2918","volume":"12","author":"MD Cordero","year":"2010","unstructured":"Cordero, M. D. et al. Mitochondrial dysfunction and mitophagy activation in blood mononuclear cells of fibromyalgia patients: Implications in the pathogenesis of the disease. Arthritis Res. Ther. 12, R17 (2010).","journal-title":"Arthritis Res. Ther."},{"key":"40781_CR74","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.mito.2015.01.010","volume":"21","author":"B S\u00e1nchez-Dom\u00ednguez","year":"2015","unstructured":"S\u00e1nchez-Dom\u00ednguez, B. et al. Oxidative stress, mitochondrial dysfunction and, inflammation common events in skin of patients with fibromyalgia. Mitochondrion 21, 69\u201375 (2015).","journal-title":"Mitochondrion"},{"key":"40781_CR75","doi-asserted-by":"crossref","unstructured":"Dos Santos, J. M. et al. Oxidative stress biomarkers and quality of life are contributing factors of muscle pain and lean body mass in patients with fibromyalgia. Biology 11 (2022).","DOI":"10.3390\/biology11060935"},{"key":"40781_CR76","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/S0016-5085(19)31517-3","volume":"73","author":"J Ahlberg","year":"1977","unstructured":"Ahlberg, J., Angelin, B., Bj\u00f6rkhem, I. & Einarsson, K. Individual bile acids in portal venous and systemic blood serum of fasting man. Gastroenterology 73, 1377\u20131382 (1977).","journal-title":"Gastroenterology"},{"key":"40781_CR77","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1136\/gut.23.8.637","volume":"23","author":"KD Setchell","year":"1982","unstructured":"Setchell, K. D., Lawson, A. M., Blackstock, E. J. & Murphy, G. M. Diurnal changes in serum unconjugated bile acids in normal man. Gut 23, 637\u2013642 (1982).","journal-title":"Gut"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40781-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40781-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40781-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:03:01Z","timestamp":1772190181000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-40781-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":77,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["40781"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-40781-3","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]},"assertion":[{"value":"27 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Eva Kosek declares the following competing interests: lecturing\/consulting for Orion Pharma, Eli Lilly, and UCB. The rest of the co-authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7735"}}